Liver Transplant
118
24
29
52
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
20 trials with published results (17%)
Research Maturity
52 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.8%
8 terminated out of 118 trials
86.7%
+0.1% vs benchmark
13%
15 trials in Phase 3/4
38%
20 of 52 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 52 completed trials
Clinical Trials (118)
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC
Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics
Letermovir for R+ Study
Assessing EUS and Percutaneous Untargeted Liver Biopsy Quality
Impact of Culture of Perfusion Fluid on Donor-derived Infection Management and Outcome in Liver and Kidney Transplant
Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Hypothermic Machine Perfusion for Liver Graft Preservation
LIFT Intervention in Liver Transplant Candidates
Liver Transplantation With Tregs at MGH
The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients
Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.
Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Transitional ePRO Diary Liver (Transitional-ePRO)
EVR and EPO for Liver Transplant Tolerance